S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Price:
20.62
CNY
1.28%
Market Closed
Market Cap:
¥13.7B
Relative Value
The Relative Value of one Shandong Pharmaceutical Glass Co Ltd stock under the Base Case scenario is 21.91 CNY. Compared to the current market price of 20.62 CNY, Shandong Pharmaceutical Glass Co Ltd is Undervalued by 6%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
21.91
CNY
Undervaluation 6%
S
Multiples Across Competitors
Competitors Multiples
Shandong Pharmaceutical Glass Co Ltd Competitors
Shandong Pharmaceutical Glass Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
13.7B CNY | 2.9 | 17.9 | 13.4 | 13.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.1 | 37 | 26.8 | 32.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.3B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.4B CHF | 3.9 | 37.8 | 15.6 | 30.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
121.7B DKK | 4.4 | 33.4 | 15.4 | 18.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.6B USD | 2.9 | 30.7 | 13.9 | 17.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.5 | 13.1 | 21.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.9B CNY | 9.4 | 26 | 23.5 | 23.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.2 | -19.2 | 19.3 | 91 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.2 | 21.1 | 13.7 | 18.6 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.2T KRW | 89.4 | -32.8 | -76 | -71.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
